Taking a solution for a clinical unmet need from a mere idea to a profitable medical device company is a long and complex process. After developing a prototype solution, the physician-inventor must quickly file a patent to protect his or her intellectual property. After the patent is secured, the first major business decision arrives: should the inventor sell the patent or maintain ownership? If the inventor decides to maintain ownership, he or she will face a series of hurdles from obtaining additional funding to device development, and ultimately, commercialization and marketing of the product.
PATENTING AN INVENTION
After the physician and his or her team have identified a clinical problem and invented a solution, patenting this solution is critical for protecting the team's ability to commercialize their medical device.
There are 3 important milestones in the process of patenting an invention: the date of conception, the date of actual reduction to practice, and the date of constructive reduction to practice. The date of conception describes when the invention was first conceived in its completed form. The date of actual reduction to practice refers to the date when a working model or prototype was completed. The date of constructive reduction is the date on which the patent application was filed.
Prior to 2013, the United States followed a "first-toinvent" patent system. Under this system, when 2 inventors filed patents for the same invention, an interference hearing before the Board of Appeals and
Interferences at the U.S. Patent Office was scheduled to determine the legal date of priority based on the date of conception for each inventor.
Although this system was designed to protect inventors' intellectual property, several major flaws, including the lengthy and costly legal process and difficulties in determining accurate dates of conception, limited its effectiveness. Therefore, in 2011, the U.S. Congress passed the America Invents Act, which introduced a "first-to-file" patent system that gives priority to the inventor who first files a patent application. Beginning on March 16, 2013, the first-to-file system took legal precedent in the United
States, the final country to adopt this system worldwide. Therefore, the date of constructive reduction to practice is now used to determine which inventor has priority over a patented technology.
Inventors must navigate the patent system under the first-to-file system in a dramatically different fashion than under the first-to-invent. Finally, although it may be possible for physicians to patent an invention on their own, hiring a patent lawyer is strongly recommended given the complexities of the patenting system and the speed with which a patent application needs to be filed under the governing first-to-file patent system. A strong relationship with a patent lawyer is also essential to ensure that the inventor is ready to protect his or her 
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SOURCES OF FUNDING
The primary difference between licensing/assigning and manufacturing a product is that the inventor will need to secure significant funding to begin Therefore, support from the private sector is almost certainly necessary to acquire as well.
Private sector funding, termed "venture capital," is typically sought from investors who are willing to DiMaio et al. This rule calls for the PowerPoint presentation to be no more than 10 slides, covering the 10 topics listed in 
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RULES OF SUCCESS
When inventors take on the challenge of manufacturing their own product, a myriad of difficult 
